CYTK Earnings

Quarterly EPS
$-1.36
Q3 2024
$-1.26
Q4 2024
$-1.36
Q1 2025
$-1.12
Q2 2025
$-2.55
Q3 2025
$-1.49
Q4 2025
$-1.67
Q1 2026
$-1.50
Q2 2026
Latest Revenue28.6M
Latest Net Income-198762000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.5028.6M-198762000-57.1%-33.9%
Q1 2026-$1.6719.4M-206031000+1,125.8%-22.8%
Q4 2025-$1.4917.8M-61782000+4.9%-18.3%
Q3 2025-$2.551.9M-306178000+318.1%-87.5%
Q2 2025-$1.1266.8M-134370000+26,714.9%+14.5%
Q1 2025-$1.361.6M-161376000+89.1%-2.3%
Q4 2024-$1.2616.9M-150020000+912.4%+8.7%
Q3 2024-$1.36463.0K-160545000+22.5%-0.7%
Q2 2024-$1.31249.0K-143318000
Q1 2024-$1.33835.0K-135643000
Q4 2023-$1.381.7M-136896000
Q3 2023-$1.35378.0K-129422000
Cytokinetics (CYTK) — Earnings